Evaxion Biotech A/SEVAX
13F holders, Q3 2024 (September 30)8holders +2
1new positions
0sold out
1famous investor
$3.11avg. 13F price*
At the end of Q3 2024, 8 institutions reported holding Evaxion Biotech A/S (EVAX) in their 13F filings, up 2 from Q2 2024. 1 opened new positions and 0 sold out. The largest holders were Armistice Capital, LLC ($1.5M), Invst, LLC ($134K) and Citadel Advisors ($46K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Evaxion Biotech A/S
- CUSIP
- 29970R204
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $46K |
| Exits | 0 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 105,825 shares bought and 12,200 shares sold, net +93,625 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 8 holders
| Armistice Capital, LLC | 0.04% | Add +23.2% | 483,000 | $1.5M |
| Invst, LLC | 0.02% | Reduce -20.0% | 43,200 | $134K |
| Citadel Advisors | 0.00% | New | 14,825 | $46K |
| Beacon Capital Management, LLC | 0.00% | No change | 4,863 | $15K |
| BlackRock, Inc. | 0.00% | — | 1,512 | $5K |
| JPMorgan Chase & Co. | 0.00% | Reduce -64.2% | 780 | $2K |
| Rhumbline Advisers | 0.00% | No change | 290 | $901 |
| SouthState Bank Corp | 0.00% | No change | 4 | $12 |
"% of holder's portfolio" is EVAX's weight in each manager's 13F, not the share of Evaxion Biotech A/S the manager owns.